We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

This study has been terminated.
(Interim analysis of efficacy trial showed no drug efficacy.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00462202
First Posted: April 18, 2007
Last Update Posted: March 3, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Collaborative Study Group (CSG)
Information provided by (Responsible Party):
Keryx Biopharmaceuticals
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: April 13, 2015